Welcome!

News Feed Item

Modified Citrus Pectin Enhances Anti-Cancer Activity of Two Botanical Formulas, Reduces Metastasis

SAN FRANCISCO, March 26, 2013 /PRNewswire/ -- New research adds to the growing body of evidence that modified citrus pectin (MCP), a natural supplement derived from the pith of citrus fruit, has a powerful effect against cancer. In a study just published in the March 2013 issue of the journal Integrative Cancer Therapies, MCP enhanced the anti-cancer effects of two botanical formulas, one for breast cancer and one for prostate cancer. The combination treatment decreased cancer cell aggressiveness, reduced migration and inhibited metastasis in highly metastatic MDA-MB-231 human breast cancer cells and aggressive, PC-3 hormone refractory human prostate cancer cells. The study was conducted by researchers at the Cancer Research Laboratory at Indiana University Health.

"Metastasis is what makes cancer so deadly," said head investigator Dr. Daniel Sliva, associate professor at the Indiana University School of Medicine. "It's no secret that specific proteins in cancer cells cause aggressive behavior. We now know that by combining modified citrus pectin with these formulas, we can further suppress aggressive cancer activity and significantly reduce metastasis."

The researchers determined that the breast and prostate formulas by themselves decreased cancer aggressiveness, measured by cell adhesion to human fibronectin, a key component in the extracellular matrix, as well as cancer cell migration and invasion. However, when combined with MCP, the anti-cancer effects of both formulas were significantly increased.

The unique anti-breast cancer formula, which contains botanically enhanced medicinal mushrooms, diindolylmethane (an active form of a compound found in cruciferous vegetables) and a variety of botanical extracts, decreased breast cancer cell adhesion by 21 %. However, when co-administered with MCP, researchers observed a 40 % decrease. The anti-cancer effects of this breast formula have been shown in previous published studies to reduce aggressive breast cancer proliferation and metastasis by up to 70 %. This is now the third peer reviewed study showing the safety and efficacy of this anti-breast cancer formula in pre-clinical models.

In addition, the unique anti-prostate cancer formula, which contains a comprehensive blend of antioxidants, herbal extracts, and botanically enhanced medicinal mushrooms, decreased prostate cancer cell adhesion by 9 % in this study. However, when MCP was added, adhesion was reduced by as much as 40 %. Cancer cell migration was also reduced by these combination therapies. This is the fourth peer reviewed published study to demonstrate the anti-cancer effects of this botanical prostate formula in pre-clinical studies.

"This study is very significant because it demonstrates the importance of combining targeted anti-cancer compounds which can work together synergistically for greater impact against the disease," said co-author and integrative medicine expert Isaac Eliaz, MD.  "MCP makes these formulas significantly more effective. Furthermore, the powerful anti-cancer actions demonstrated by these combinations offer a safe and effective adjuvant therapy to patients with aggressive cancers who wish to increase the efficacy of their current treatment regimen."

The researchers also investigated levels of urokinase plasminogen activator (uPA), a protein marker for aggressive cancers. High uPA levels have been found to promote cancer cell adhesion, migration and invasion. Both formulas have been shown in previous research to reduce uPA. Again, combining these formulas with MCP resulted in further suppression of uPA.

Numerous studies have shown that MCP binds and blocks galectin-3, a signaling protein associated with cancer aggressiveness, angiogenesis, aggregation and metastasis. MCP has also been found to significantly increase the immune response including natural killer (NK) cell activation, with demonstrated activity against human leukemia cells. Furthermore, in addition to its synergistic actions with botanical formulas, MCP has been shown to work synergistically with chemotherapeutic agents, such as doxorubicin, allowing for greater efficacy, lower dosages and fewer side effects.

Source: Jiang J, Eliaz I, Sliva D. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells. Integr Cancer Ther. 2013 Mar;12(2):145-52

About Better Health Publishing

Better Health Publishing (BHP) focuses on the publication of key works promoting health and wellness. BHP believes that education and accessible information are the core components of a healthy and sustainable society.

This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com.

SOURCE Better Health Publishing

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
HyperConvergence came to market with the objective of being simple, flexible and to help drive down operating expenses. It reduced the footprint by bundling the compute/storage/network into one box. This brought a new set of challenges as the HyperConverged vendors are very focused on their own proprietary building blocks. If you want to scale in a certain way, let's say you identified a need for more storage and want to add a device that is not sold by the HyperConverged vendor, forget about it...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
At the keynote this morning we spoke about the value proposition of Nutanix, of having a DevOps culture and a mindset, and the business outcomes of achieving agility and scale, which everybody here is trying to accomplish," noted Mark Lavi, DevOps Solution Architect at Nutanix, in this SYS-CON.tv interview at @DevOpsSummit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
In his session at 21st Cloud Expo, James Henry, Co-CEO/CTO of Calgary Scientific Inc., introduced you to the challenges, solutions and benefits of training AI systems to solve visual problems with an emphasis on improving AIs with continuous training in the field. He explored applications in several industries and discussed technologies that allow the deployment of advanced visualization solutions to the cloud.
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen...
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost ...
From 2013, NTT Communications has been providing cPaaS service, SkyWay. Its customer’s expectations for leveraging WebRTC technology are not only typical real-time communication use cases such as Web conference, remote education, but also IoT use cases such as remote camera monitoring, smart-glass, and robotic. Because of this, NTT Communications has numerous IoT business use-cases that its customers are developing on top of PaaS. WebRTC will lead IoT businesses to be more innovative and address...
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Your homes and cars can be automated and self-serviced. Why can't your storage? From simply asking questions to analyze and troubleshoot your infrastructure, to provisioning storage with snapshots, recovery and replication, your wildest sci-fi dream has come true. In his session at @DevOpsSummit at 20th Cloud Expo, Dan Florea, Director of Product Management at Tintri, provided a ChatOps demo where you can talk to your storage and manage it from anywhere, through Slack and similar services with...
Evan Kirstel is an internationally recognized thought leader and social media influencer in IoT (#1 in 2017), Cloud, Data Security (2016), Health Tech (#9 in 2017), Digital Health (#6 in 2016), B2B Marketing (#5 in 2015), AI, Smart Home, Digital (2017), IIoT (#1 in 2017) and Telecom/Wireless/5G. His connections are a "Who's Who" in these technologies, He is in the top 10 most mentioned/re-tweeted by CMOs and CIOs (2016) and have been recently named 5th most influential B2B marketeer in the US. H...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.